OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142–5p/PD-L1 axis
Junjun Ling, Qinghua Sun, Tian Qin, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 731, pp. 109449-109449
Closed Access | Times Cited: 14

Showing 14 citing articles:

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 27

HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor
Peng Qiu, Lujuan Wang, Liang Zuo, et al.
Cancer Gene Therapy (2023) Vol. 31, Iss. 1, pp. 9-17
Closed Access | Times Cited: 22

miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation
Parisa Zareifar, Hani Moslem Ahmed, Pouya Ghaderi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 8

Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions
Jiatian Ye, Lan Zheng, Yuedong He, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 18

HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway
Georgios Konstantopoulos, Danai Leventakou, Despoina-Rozi Saltiel, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 113-113
Open Access | Times Cited: 2

Future directions in cervical cancer treatment
Botle Precious Damane, Thanyani Victor Mulaudzi, Mahlatse Cordelia Kgokolo, et al.
Elsevier eBooks (2024), pp. 155-177
Closed Access | Times Cited: 2

Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
Christoforos Vaxevanis, Michael Bachmann, Barbara Seliger
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009774-e009774
Open Access | Times Cited: 2

NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs
Margarita Kniazeva, Lidia Zabegina, Andrey Shalaev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9114-9114
Open Access | Times Cited: 1

Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions
Ting Feng, Bei Cheng, Wenchao Sun, et al.
BMC Women s Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1

The programed death‐1/programed death ligand‐1 axis and its potential as a therapeutic target for virus‐associated tumours
Jing Li, Yan Zhang, Bing Luo
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access

Page 1

Scroll to top